143 related articles for article (PubMed ID: 21456010)
1. Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia.
Konoplev S; Jorgensen JL; Thomas DA; Lin E; Burger J; Kantarjian HM; Andreeff M; Medeiros LJ; Konopleva M
Cancer; 2011 Oct; 117(20):4689-95. PubMed ID: 21456010
[TBL] [Abstract][Full Text] [Related]
2. CXC chemokine receptor 4 expression, CXC chemokine receptor 4 activation, and wild-type nucleophosmin are independently associated with unfavorable prognosis in patients with acute myeloid leukemia.
Konoplev S; Lin P; Yin CC; Lin E; Nogueras González GM; Kantarjian HM; Andreeff M; Medeiros LJ; Konopleva M
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):686-92. PubMed ID: 24035716
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated CXCR4 expression has a positive prognostic impact in colorectal cancer.
Weixler B; Renetseder F; Facile I; Tosti N; Cremonesi E; Tampakis A; Delko T; Eppenberger-Castori S; Tzankov A; Iezzi G; Kettelhack C; Soysal SD; von Holzen U; Spagnoli GC; Terracciano L; Tornillo L; Droeser RA; Däster S
Cell Oncol (Dordr); 2017 Dec; 40(6):609-619. PubMed ID: 28936810
[TBL] [Abstract][Full Text] [Related]
4. Relationship between CXC chemokine receptor 4 expression and prognostic significance in acute myeloid leukemia.
Cao T; Ye Y; Liao H; Shuai X; Jin Y; Su J; Zheng Q
Medicine (Baltimore); 2019 Jun; 98(23):e15948. PubMed ID: 31169718
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.
Thomas DA; O'Brien S; Jorgensen JL; Cortes J; Faderl S; Garcia-Manero G; Verstovsek S; Koller C; Pierce S; Huh Y; Wierda W; Keating MJ; Kantarjian HM
Blood; 2009 Jun; 113(25):6330-7. PubMed ID: 18703706
[TBL] [Abstract][Full Text] [Related]
6. High CXCR4 and low VLA-4 expression predicts poor survival in adults with acute lymphoblastic leukemia.
Ko SY; Park CJ; Park SH; Cho YU; Jang S; Seo EJ; Kim N; Kim DY; Koh KN; Im HJ; Seo JJ; Chi HS
Leuk Res; 2014 Jan; 38(1):65-70. PubMed ID: 24239175
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of CXCR4 in acute myeloid leukemia.
Ahn JY; Seo K; Weinberg OK; Arber DA
Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):79-84. PubMed ID: 22914607
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens.
Jain P; Gu J; Kanagal-Shamanna R; Tang Z; Patel KP; Yao H; Fang L; Bao HY; Liu CH; Lin P; Medeiros LJ; Lu X
Leuk Res; 2019 Sep; 84():106176. PubMed ID: 31279181
[TBL] [Abstract][Full Text] [Related]
9. High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.
Walther F; Berther JL; Lalos A; Ramser M; Eichelberger S; Mechera R; Soysal S; Muenst S; Posabella A; Güth U; Stadlmann S; Terracciano L; Droeser RA; Zeindler J; Singer G
BMC Cancer; 2022 Apr; 22(1):376. PubMed ID: 35397601
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.
Konoplev S; Rassidakis GZ; Estey E; Kantarjian H; Liakou CI; Huang X; Xiao L; Andreeff M; Konopleva M; Medeiros LJ
Cancer; 2007 Mar; 109(6):1152-6. PubMed ID: 17315232
[TBL] [Abstract][Full Text] [Related]
11. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
[TBL] [Abstract][Full Text] [Related]
12. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
[TBL] [Abstract][Full Text] [Related]
13. CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemia.
Craddock KJ; Chen Y; Brandwein JM; Chang H
Leuk Res; 2013 Jul; 37(7):759-64. PubMed ID: 23643324
[TBL] [Abstract][Full Text] [Related]
14. No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia.
Dai Q; Liu X; Yang H; Guo S; Wang Y; Peng L; Ye L; Chen L; Lai C; Chen Q; Zhang G; Jiang Y
Leuk Res; 2018 May; 68():57-61. PubMed ID: 29544133
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group.
Bradstock K; Matthews J; Benson E; Page F; Bishop J
Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437
[TBL] [Abstract][Full Text] [Related]
16. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia.
Crazzolara R; Kreczy A; Mann G; Heitger A; Eibl G; Fink FM; Möhle R; Meister B
Br J Haematol; 2001 Dec; 115(3):545-53. PubMed ID: 11736934
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.
Gaikwad AS; Donohue RE; Elghetany MT; Sheehan AM; Lu XY; Gramatges MM; McClain KL; Mistretta TA; Punia JN; Moore TJ; Goltsova T; Cubbage M; Curry CV
Int J Clin Exp Pathol; 2014; 7(9):6225-30. PubMed ID: 25337274
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.
Shin HC; Seo J; Kang BW; Moon JH; Chae YS; Lee SJ; Lee YJ; Han S; Seo SK; Kim JG; Sohn SK; Park TI
Korean J Intern Med; 2014 Nov; 29(6):785-92. PubMed ID: 25378977
[TBL] [Abstract][Full Text] [Related]
19. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
Topp MS; Gökbuget N; Stein AS; Zugmaier G; O'Brien S; Bargou RC; Dombret H; Fielding AK; Heffner L; Larson RA; Neumann S; Foà R; Litzow M; Ribera JM; Rambaldi A; Schiller G; Brüggemann M; Horst HA; Holland C; Jia C; Maniar T; Huber B; Nagorsen D; Forman SJ; Kantarjian HM
Lancet Oncol; 2015 Jan; 16(1):57-66. PubMed ID: 25524800
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.
Aricò M; Schrappe M; Hunger SP; Carroll WL; Conter V; Galimberti S; Manabe A; Saha V; Baruchel A; Vettenranta K; Horibe K; Benoit Y; Pieters R; Escherich G; Silverman LB; Pui CH; Valsecchi MG
J Clin Oncol; 2010 Nov; 28(31):4755-61. PubMed ID: 20876426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]